New Concepts for Basal Cell Carcinoma. Demographic, Clinical, Histological Risk Factors, and Biomarkers. A Systematic Review of Evidence Regarding Risk for Tumor Development, Susceptibility for Second Primary and Recurrence

Journal of Surgical Research

Volumn 159, Issue 1, 2010, Pages 545-556

  Kyrgidis, Athanassios ^a   Tzellos, Thrasivoulos George ^c   Vahtsevanos, Konstantinos ^a   Triaridis, Stefanos ^b  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

basal cell; carcinoma; clinical; demographic; epidemiology; gene; histology; multiple tumor; recurrence; risk factor; second primary; skin; tumor site

Indexed keywords

REACTIVE OXYGEN METABOLITE; TUMOR MARKER;

APOPTOSIS; BASAL CELL CARCINOMA; BODY MASS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CELL GROWTH; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DETOXIFICATION; DIETARY INTAKE; DNA DAMAGE; GENETIC POLYMORPHISM; GENOMIC INSTABILITY; GENOTYPE; GROUPS BY AGE; HEALTH CARE COST; HEPATITIS B VIRUS; HEREDITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RADIATION CARCINOGENESIS; RECURRENCE RISK; RECURRENT CANCER; REVIEW; RISK ASSESSMENT; RISK REDUCTION; RURAL POPULATION; SECOND CANCER; SEX DIFFERENCE; SKIN CARCINOGENESIS; SYSTEMATIC REVIEW; TREATMENT PLANNING; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URBAN POPULATION; X CHROMOSOME INACTIVATION;

CARCINOMA, BASAL CELL; GENOMIC INSTABILITY; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; ULTRAVIOLET RAYS;

EID: 77049121810     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.11.834     Document Type: Review

References (86)

1. Valery P.C., Neale R., Williams G., et al. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: A 10-year longitudinal study. J Investig Dermatol Symp Proc 9 (2004) 148
2. Bath-Hextall FJ, Perkins W, Bong J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev CD003412, 2007.
3. Madan V., Hoban R.R., Strange R.C., et al. Genetics and risk factors for basel cell carcinoma. Br J Dermatol 154 Suppl 1 (2006) 5
4. Kyrgidis A., Kountouras J., Zavos C., et al. New molecular concepts of Barrett's esophagus: Clinical implications and biomarkers. J Surg Res 125 (2005) 189
5. van Steensel M.A., and Frank J. Monoclonal origin of anatomically distinct basal cell carcinomas: Is there really hard evidence at hand?. J Invest Dermatol 126 (2006) 2727
6. Han J., Kraft P., Colditz G.A., et al. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 119 (2006) 1976
7. Box N.F., Duffy D.L., Irving R.E., et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 116 (2001) 224
8. Brudnik U., Branicki W., Wojas-Pelc A., et al. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. Exp Dermatol (2009) In Press
9. Mizuno T., Tokuoka S., Kishikawa M., et al. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis 27 (2006) 2286
10. Gudbjartsson D.F., Sulem P., Stacey S.N., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40 (2008) 886
11. Hall J., Artuso M., and English D.R. Molecular epidemiology of skin cancers: DNA repair and non-melanocytic skin cancer. Ann Ist Super Sanita 32 (1996) 43
12. Dybdahl M., Vogel U., Frentz G., et al. Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 8 (1999) 77
13. Lovatt T., Alldersea J., Lear J.T., et al. Polymorphism in the nuclear excision repair gene ERCC2/XPD: Association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum Mutat 25 (2005) 353
14. Han J., Hankinson S.E., Colditz G.A., et al. Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br J Cancer 91 (2004) 1604
15. Han J., Colditz G.A., Liu J.S., et al. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1539
16. Thirumaran R.K., Bermejo J.L., Rudnai P., et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27 (2006) 1676
17. Yin J., Rockenbauer E., Hedayati M., et al. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of Basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 11 (2002) 1449
18. Han J., Colditz G.A., Samson L.D., et al. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 64 (2004) 3009
19. Miller K.L., Karagas M.R., Kraft P., et al. XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 27 (2006) 1670
20. Han J., Colditz G.A., and Hunter D.J. Manganese superoxide dismutase polymorphism and risk of skin cancer (United States). Cancer Causes Control 18 (2007) 79
21. Han J., Colditz G.A., and Hunter D.J. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28 (2007) 390-397
22. Heagerty A.H., Fitzgerald D., Smith A., et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumors. Lancet 343 (1994) 266
23. Strange R.C., Lear J.T., and Fryer A.A. Glutathione S-transferase polymorphisms: Influence on susceptibility to cancer. Chem Biol Interact 111-112 (1998) 351
24. Ramachandran S., Fryer A.A., Smith A.G., et al. Basal cell carcinomas: Association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. Pharmacogenetics 11 (2001) 247
25. Yengi L., Inskip A., Gilford J., et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 56 (1996) 1974
26. Clairmont A., Sies H., Ramachandran S., et al. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis 20 (1999) 1235
27. Ramachandran S., Fryer A.A., Lovatt T.J., et al. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: Use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett 189 (2003) 175
28. Ramachandran S., Hoban P.R., Ichii-Jones F., et al. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: Association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumors. Pharmacogenetics 10 (2000) 545
29. Strange R.C., El-Genidy N., Ramachandran S., et al. Susceptibility to basal cell carcinoma: Associations with PTCH polymorphisms. Ann Hum Genet 68 (2004) 536
30. Moloney F.J., Comber H., O'Lorcain P., et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 154 (2006) 498
31. Altaee I.K., Jaleel N.A., Aljubury H.M., et al. Incidence and types of malignancies in renal transplant recipients in Iraq. Saudi J Kidney Dis Transpl 17 (2006) 408
32. Hajeer A.H., Lear J.T., Ollier W.E., et al. Preliminary evidence of an association of tumor necrosis factor microsatellites with increased risk of multiple basal cell carcinomas. Br J Dermatol 142 (2000) 441
33. Skov L., Allen M.H., Bang B., et al. Basal cell carcinoma is associated with high TNF-alpha release but nor with TNF-α polymorphism at position -308. Exp Dermatol 12 (2003) 772
34. Rompel R., Petres J., Kaupert K., et al. HLA phenotypes and multiple basal cell carcinomas. Dermatology 189 (1994) 222
35. Wilkening S., Hemminki K., Rudnai P., et al. No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin. Br J Dermatol 157 (2007) 375
36. Parrella P., Mazzarelli P., Signori E., et al. Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer. J Clin Pathol 59 (2006) 1181
37. Yerebakan O., Ciftcioglu M.A., Akkaya B.K., et al. Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma. J Dermatol 30 (2003) 33
38. Wimmer E., Kraehn-Senftleben G., and Issing W.J. HER3 expression in cutaneous tumors. Anticancer Res 28 (2008) 973
39. Bendesky A., Rosales A., Salazar A.M., et al. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer. Mutat Res 619 (2007) 38
40. Han J., Cox D.G., Colditz G.A., et al. The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women. Mol Carcinog 45 (2006) 694
41. Appel T., Bierhoff E., Appel K., et al. Predictive variables for the biological behavior of basal cell carcinoma of the face: Relevance of morphometry of the nuclei. Br J Oral Maxillofac Surg 41 (2003) 147
42. Janisson-Dargaud D., Durlach A., Lorenzato M., et al. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol 35 (2008) 916
43. Delfino S., Innocenzi D., Di L.G., et al. An increase in basal cell carcinoma among the young: An epidemiological study in a middle-south Italian population. Anticancer Res 26 (2006) 4979
44. Bivens M.M., Bhosle M., Balkrishnan R., et al. Nonmelanoma skin cancer: Is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 32 (2006) 1473
45. Revenga A.F., Paricio Rubio J.F., Mar Vazquez S.M., et al. Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: A hospital-based survey. J Eur Acad Dermatol Venereol 18 (2004) 137
46. Davies T.W., Treasure F.P., Welch A.A., et al. Diet and basal cell skin cancer: Results from the EPIC-Norfolk cohort. Br J Dermatol 146 (2002) 1017
47. Granger R.H., Blizzard L., Fryer J.L., et al. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs. BMC Cancer 6 (2006) 141
48. McNaughton S.A., Marks G.C., Gaffney P., et al. Antioxidants and basal cell carcinoma of the skin: A nested case-control study. Cancer Causes Control 16 (2005) 609
49. Olsen C.M., Hughes M.C., Pandeya N., et al. Anthropometric measures in relation to basal cell carcinoma: A longitudinal study. BMC Cancer 6 (2006) 82
50. Fung T.T., Hunter D.J., Spiegelman D., et al. Intake of alcohol and alcoholic beverages and the risk of basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 11 (2002) 1119
51. Freedman D.M., Sigurdson A., Doody M.M., et al. Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prev 12 (2003) 1540
52. Grau M.V., Baron J.A., Langholz B., et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 119 (2006) 682
53. Rees J.R., Stukel T.A., Perry A.E., et al. Tea consumption and basal cell and squamous cell skin cancer: Results of a case-control study. J Am Acad Dermatol 56 (2007) 781
54. Duffield-Lillico A.J., Slate E.H., Reid M.E., et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95 (2003) 1477
55. Neale R.E., Davis M., Pandeya N., et al. Basal cell carcinoma on the trunk is associated with excessive sun exposure. J Am Acad Dermatol 56 (2007) 380
56. van Dam R.M., Huang Z., Rimm E.B., et al. Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study. Am J Epidemiol 150 (1999) 459
57. Bouwes Bavinck J.N., Euvrard S., Naldi L., et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: A case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127 (2007) 1647
58. Lovatt T.J., Lear J.T., Bastrilles J., et al. Associations between UVR exposure and basal cell carcinoma site and histology. Cancer Lett 216 (2004) 191
59. Ramos J., Villa J., Ruiz A., et al. UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 2006
60. Han J., Colditz G.A., and Hunter D.J. Risk factors for skin cancers: A nested case-control study within the Nurses' Health Study. Int J Epidemiol 35 (2006) 1514
61. Boyd A.S., and Shyr Y. King LE Jr. Basal cell carcinoma in young women: An evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol 46 (2002) 706
62. Pandeya N., Purdie D.M., Green A., et al. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: Follow-up data from the Nambour Skin Cancer Prevention Trial. Am J Epidemiol 161 (2005) 748
63. van der Pols J.C., Williams G.M., Pandeya N., et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 15 (2006) 2546
64. Bath-Hextall F., Leonardi-Bee J., Somchand N., et al. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev: CD005414 (2007)
65. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 199;135:781.
66. Marehbian J., Colt J.S., Baris D., et al. Occupation and keratinocyte cancer risk: A population-based case-control study. Cancer Causes Control 18 (2007) 895
67. Yoshinaga S., Hauptmann M., Sigurdson A.J., et al. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. Int J Cancer 115 (2005) 828
68. Perkins J.L., Liu Y., Mitby P.A., et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: A report from the childhood cancer survivor study. J Clin Oncol 23 (2005) 3733
69. Levi F., Moeckli R., Randimbison L., et al. Skin cancer in survivors of childhood and adolescent cancer. Eur J Cancer 42 (2006) 656
70. Hassanpour S.E., Kalantar-Hormozi A., Motamed S., et al. Basal cell carcinoma of scalp in patients with history of childhood therapeutic radiation: A retrospective study and comparison to nonirradiated patients. Ann Plast Surg 57 (2006) 509
71. Forslund O., Lindelof B., Hradil E., et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol 123 (2004) 388
72. Karagas M.R., Nelson H.H., Sehr P., et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98 (2006) 389
73. Bath-Hextall F., Leonardi-Bee J., Smith C., et al. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 121 (2007) 2105
74. Marcil I., and Stern R.S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol 136 (2000) 1524
75. Levi F., Randimbison L., Maspoli M., et al. High incidence of second basal cell skin cancers. Int J Cancer 119 (2006) 1505
76. Schinstine M., and Goldman G.D. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery. J Am Acad Dermatol 44 (2001) 497
77. Graells J. The risk and risk factors of a second non-melanoma skin cancer: A study in a Mediterranean population. J Eur Acad Dermatol Venereol 18 (2004) 142
78. Allen S.B., Lortscher D.N., and Sengelmann R.D. Earlier detection of patients' second primary basal cell carcinomas: A quantitative analysis. Dermatol Surg 33 (2007) 69
79. Karagas M.R., Greenberg E.R., Spencer S.K., et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81 (1999) 555
80. Madan V., Hoban P.R., Strange R.C., et al. Prognostic factors for a subsequent basal cell carcinoma: Implications for follow-up. Br J Dermatol 155 (2006) 217
81. van Iersel C.A., van de Velden H.V., Kusters C.D., et al. Prognostic factors for a subsequent basal cell carcinoma: Implications for follow-up. Br J Dermatol 153 (2005) 1078
82. Boztepe G., Hohenleutner S., Landthaler M., et al. Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis. Acta Derm Venereol 84 (2004) 218
83. Nagore E., Grau C., Molinero J., et al. Positive margins in basal cell carcinoma: Relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 17 (2003) 167
84. Walker P., and Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 47 (2006) 1
85. Shulman O., Laitman Y., Vilan A., et al. Monoclonal origin of anatomically distinct basal cell carcinomas. J Invest Dermatol 126 (2006) 676
86. Siegele B., Cefalu C., Holm N., et al. eIF4E-targeted suicide gene therapy in a Minimal Residual Mouse Model for Metastatic Soft-Tissue Head and Neck Squamous. J Surg Res 148 (2008) 83